ClinicalTrials.Veeva

Menu

Sleep TMS for Depression

Stanford University logo

Stanford University

Status

Not yet enrolling

Conditions

Major Depression
Sleep

Treatments

Device: TMS

Study type

Interventional

Funder types

Other

Identifiers

NCT06824415
60980-3

Details and patient eligibility

About

The goal of this study is to establish the feasibility, tolerability, and preliminary efficacy of sleep-state transcranial magnetic stimulation (TMS) for enhancing plasticity in depression treatment.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Current Major Depressive Disorder (MDD) diagnosis
  • Failed >= 1 antidepressant medication
  • Moderate-to-severe depression

Exclusion criteria

  • Intellectual disability
  • Significant head injury/neurological disorder
  • Pregnancy or postpartum
  • TMS/MRI contraindications
  • Active substance use/suicidal ideation

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

15 participants in 2 patient groups

Active TMS, Sham TMS
Experimental group
Description:
Participants will receive 2 sessions of Transcranial Magnetic Stimulation (TMS) delivered using standard intermittent theta-burst (iTBS) parameters (600 pulses, 3 min, 120% rMT). Participants will receive, on separate sessions, either active or sham iTBS delivered during pre-sleep wakefulness or NREM sleep stages while recording with Electroencephalography (EEG). Participants will perform the N-back task and Multi-source Interference Task (MSIT) during each session to measure working memory and cognitive control performance.
Treatment:
Device: TMS
Sham TMS, Active TMS
Experimental group
Description:
Participants will receive 2 sessions of Transcranial Magnetic Stimulation (TMS) delivered during using standard intermittent theta-burst (iTBS) parameters (600 pulses, 3 min, 120% rMT). Participants will receive, on separate sessions, either active or sham iTBS delivered during pre-sleep wakefulness or NREM sleep stages while recording with Electroencephalography (EEG). Participants will perform the N-back task and Multi-source Interference Task (MSIT) during each session to measure working memory and cognitive control performance.
Treatment:
Device: TMS

Trial contacts and locations

1

Loading...

Central trial contact

Jade T Truong, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems